Becker, Kristian C.
Kwee, Lydia Coulter
Neely, Megan L.
Grass, Elizabeth
Jakubowski, Joseph A.
Fox, Keith A. A.
White, Harvey D.
Gregory, Simon G.
Gurbel, Paul A.
Carvalho, Leonardo de Pinto
Becker, Richard C.
Magnus Ohman, E.
Roe, Matthew T.
Shah, Svati H.
Chan, Mark Y.
Article History
Received: 9 September 2019
Accepted: 24 March 2020
First Online: 10 April 2020
Competing interests
: The TRILOGY-ACS trial (ClinicalTrials.gov number, NCT00699998) and sub-studies were supported by Daiichi Sankyo Incorporated and Eli Lilly and Company. J.A. Jakubowski is a former employee of Eli Lilly. K.A.A. Fox reports receiving research grants from AstraZeneca and the British Heart Foundation. H.D. White reports receiving consulting/advisory board payments from AstraZeneca, Merck Sharpe & Dohme, Roche, and Regado Biosciences, and research grants from Sanofi-Aventis, Eli Lilly, The Medicines Company, NIH, Roche, Merck Sharpe & Dohme, AstraZeneca, GlaxoSmithKline, and Daiichi Sankyo Pharma Development. S.G. Gregory reports receiving research grants from NIH, DoD, and the Prostate Cancer Foundation. P.A. Gurbel reports receiving grants from: The National Institutes of Health, Bayer, Medicure, Instrumentation Labs, USWorld Medicals, Haemonetics, Amgen, Idorsia, Ionis, Janssen, and Merck. He reports receiving honoraria, payment for lectures, and consultations on speakers’ bureaus from: Bayer, Janssen, Merck, UptoDate, and Medicure. He holds patents in the area of personalized antiplatelet therapy and interventional cardiology. R.C. Becker reports receiving grant support from AstraZeneca, BMS/Sanofi Partnership, Johnson & Johnson, Bayer, honoraria from AstraZeneca and Daiichi/Eli Lilly and consultant for Portola Pharmaceuticals, and Boehringer-Ingelheim. E.M. Ohman reports receiving research grants from Daiichi Sankyo, Eli Lilly, and Gilead, and consulting/ advisory board payments from AstraZeneca, Daiichi Sankyo, Eli Lilly, Gilead, The Medicines Company, WebMD, Abiomed, Sanofi-Aventis, and Janssen. M.T. Roe reports receiving consulting/advisory board/other payments from Eli Lilly, Janssen, Elsevier, AstraZeneca, Merck, Amgen, and Bristol-Myers Squibb. S.H. Shah reports receiving research grants from NIH, NHLBI, Health Effects Institute and the American Heart Association and family members receiving consulting/ advisory board payments from Biosense Webster and Apama Medical. M.Y. Chan receives salary support from a National Medical Research Council (Singapore) Clinician-Scientist Award (NMRC/CSA-INV/0001/2016) and a research grant from Eli Lilly. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.